Cargando…

The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer

The aim of our study was to determine the importance of p53, PCNA and Ki–67, evaluated by immunohistochemistry, in the treatment and prediction of the laryngeal carcinoma. Out of a total of 319 patients with laryngeal carcinoma that underwent surgery in our department between 1999 and 2007, we perfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarafoleanu, D, Postelnicu, V, Iosif, C, Manea, C, Sarafoleanu, C
Formato: Texto
Lenguaje:English
Publicado: Carol Davila University Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018987/
https://www.ncbi.nlm.nih.gov/pubmed/20108544
_version_ 1782196137127575552
author Sarafoleanu, D
Postelnicu, V
Iosif, C
Manea, C
Sarafoleanu, C
author_facet Sarafoleanu, D
Postelnicu, V
Iosif, C
Manea, C
Sarafoleanu, C
author_sort Sarafoleanu, D
collection PubMed
description The aim of our study was to determine the importance of p53, PCNA and Ki–67, evaluated by immunohistochemistry, in the treatment and prediction of the laryngeal carcinoma. Out of a total of 319 patients with laryngeal carcinoma that underwent surgery in our department between 1999 and 2007, we performed a retrospective study on 71 cases who benefited by immunohistochemical guidance before thebeginning of the treatment. All these patients have been followed–up two to five years after surgery. The values of p53, PCNA and Ki–67 are strongly correlated with the histological grading, by means of descriptive statistics (confidence level 95%); the mean values of these three markers corresponding to each HP grade. A highly statistical significant positive correlation (r = 0.84, p<0.001) between the values of p53 and PCNA was observed. The values of p53, PCNA and Ki–67 in the patients from this study are strongly correlated with the absence of the loco–regional lymph node metastases, by means of descriptive statistics(confidence level 95%). Ki–67 only is correlated significantly to the presence of lymphatic metastases in the regional lymph nodes (stage N1, N2 or N3 TNM). P53 and PCNA are not correlated significantly with the presence of the metastases in the regional lymph nodes.
format Text
id pubmed-3018987
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-30189872011-03-03 The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer Sarafoleanu, D Postelnicu, V Iosif, C Manea, C Sarafoleanu, C J Med Life Case Presentation The aim of our study was to determine the importance of p53, PCNA and Ki–67, evaluated by immunohistochemistry, in the treatment and prediction of the laryngeal carcinoma. Out of a total of 319 patients with laryngeal carcinoma that underwent surgery in our department between 1999 and 2007, we performed a retrospective study on 71 cases who benefited by immunohistochemical guidance before thebeginning of the treatment. All these patients have been followed–up two to five years after surgery. The values of p53, PCNA and Ki–67 are strongly correlated with the histological grading, by means of descriptive statistics (confidence level 95%); the mean values of these three markers corresponding to each HP grade. A highly statistical significant positive correlation (r = 0.84, p<0.001) between the values of p53 and PCNA was observed. The values of p53, PCNA and Ki–67 in the patients from this study are strongly correlated with the absence of the loco–regional lymph node metastases, by means of descriptive statistics(confidence level 95%). Ki–67 only is correlated significantly to the presence of lymphatic metastases in the regional lymph nodes (stage N1, N2 or N3 TNM). P53 and PCNA are not correlated significantly with the presence of the metastases in the regional lymph nodes. Carol Davila University Press 2009-04-15 2009-04-25 /pmc/articles/PMC3018987/ /pubmed/20108544 Text en ©Carol Davila University Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Presentation
Sarafoleanu, D
Postelnicu, V
Iosif, C
Manea, C
Sarafoleanu, C
The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer
title The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer
title_full The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer
title_fullStr The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer
title_full_unstemmed The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer
title_short The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer
title_sort role of p53, pcna and ki–67 as outcome predictors in the treatment of laryngeal cancer
topic Case Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018987/
https://www.ncbi.nlm.nih.gov/pubmed/20108544
work_keys_str_mv AT sarafoleanud theroleofp53pcnaandki67asoutcomepredictorsinthetreatmentoflaryngealcancer
AT postelnicuv theroleofp53pcnaandki67asoutcomepredictorsinthetreatmentoflaryngealcancer
AT iosifc theroleofp53pcnaandki67asoutcomepredictorsinthetreatmentoflaryngealcancer
AT maneac theroleofp53pcnaandki67asoutcomepredictorsinthetreatmentoflaryngealcancer
AT sarafoleanuc theroleofp53pcnaandki67asoutcomepredictorsinthetreatmentoflaryngealcancer
AT sarafoleanud roleofp53pcnaandki67asoutcomepredictorsinthetreatmentoflaryngealcancer
AT postelnicuv roleofp53pcnaandki67asoutcomepredictorsinthetreatmentoflaryngealcancer
AT iosifc roleofp53pcnaandki67asoutcomepredictorsinthetreatmentoflaryngealcancer
AT maneac roleofp53pcnaandki67asoutcomepredictorsinthetreatmentoflaryngealcancer
AT sarafoleanuc roleofp53pcnaandki67asoutcomepredictorsinthetreatmentoflaryngealcancer